The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Medipal Holdings's share price is 円2470.00.
Medipal Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円16,558.30. Hence, Medipal Holdings's PS Ratio for today is 0.15.
The historical rank and industry rank for Medipal Holdings's PS Ratio or its related term are showing as below:
TSE:7459'
s PS Ratio Range Over the Past 10 Years
Min: 0.09 Med: 0.14 Max: 0.2
Current: 0.15
During the past 13 years, Medipal Holdings's highest PS Ratio was 0.20. The lowest was 0.09. And the median was 0.14.
TSE:7459's PS Ratio is ranked better than 85.42% of 96
companies
in the Medical Distribution industry
Industry Median: 0.495
vs TSE:7459: 0.15
Medipal Holdings Corp has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Medipal Holdings was 8.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 3.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 2.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 1.90% per year.
During the past 13 years, Medipal Holdings's highest 3-Year average Revenue per Share Growth Rate was 5.80% per year. The lowest was 0.20% per year. And the median was 3.05% per year.
Back to Basics: PS Ratio
Medipal Holdings PS Ratio Historical Data
The historical data trend for Medipal Holdings's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medipal Holdings's PS Ratio
For the Medical Distribution subindustry, Medipal Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings's PS Ratio Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's PS Ratio falls into.
Medipal Holdings PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Medipal Holdings's Share Price of today is 円2470.00. Medipal Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円16,558.30.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Medipal Holdings PS Ratio Related Terms
Thank you for viewing the detailed overview of Medipal Holdings's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:7459 has been successfully added to your 